Risedronate - Latest Advances

Risedronate attenuates renal fibrosis by targeting prenylation-dependent RhoA/ROCK1 and ERK/NF-κB signaling.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: September 20, 2025

Severe cutaneous adverse reactions to anti-osteoporosis drugs: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database and a review of published cases.

Journal: Frontiers in pharmacology

Published: September 18, 2025

Association of Osteoporosis and Bone-Strengthening Medications with Postoperative Outcomes Following Transforaminal Lumbar Interbody Fusion.

Journal: World neurosurgery

Published: September 15, 2025

Prescription Trends by Orthopedic Surgery Provider: Review of the Medicare Part D Prescribers - by Provider and Drug, 2013-2021.

Journal: Orthopedics

Published: August 11, 2025

Drug repurposing for osteoarthritis disease modification in the early 21st century.

Journal: Connective tissue research

Published: August 02, 2025

Bisphosphonate-related ocular adverse events: a pharmacovigilance study based on the FAERS database.

Journal: Endocrine connections

Published: July 30, 2025

γ9δ2 T cells detect mevalonate diphosphate via BTN3A3.

Journal: Cellular and molecular life sciences : CMLS

Published: July 24, 2025

Transdermal delivery of risedronate via spanlastics for osteoporosis: formulation optimization, skin deposition, and pharmacokinetic assessment.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: July 21, 2025

Pharmacovigilance-Based Identification and Mechanistic Exploration of Periodontitis-Related Drugs.

Journal: Journal of clinical periodontology

Published: June 28, 2025

A Systematic Review on the Efficacy of Bisphosphonates on Osteogenesis Imperfecta.

Journal: Cureus

Published: June 22, 2025

Encapsulating Pt NCs with an AIE effect into a metal-organic framework as a novel fluorescence nanoprobe for discriminatively detecting bisphosphonate drugs.

Journal: Analytical and bioanalytical chemistry

Published: June 03, 2025

Preclinical Study of Pain Neuropeptide Expression in Murine Sensory Neurons Induced by Irradiated Osteoclasts in the Context of Stereotactic Body Radiation Therapy.

Journal: Cells

Published: June 03, 2025

Filters

Risedronate attenuates renal fibrosis by targeting prenylation-dependent RhoA/ROCK1 and ERK/NF-κB signaling.

Risedronate attenuates renal fibrosis by targeting prenylation-dependent RhoA/ROCK1 and ERK/NF-κB signaling.

Severe cutaneous adverse reactions to anti-osteoporosis drugs: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database and a review of published cases.

Severe cutaneous adverse reactions to anti-osteoporosis drugs: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database and a review of published cases.

Association of Osteoporosis and Bone-Strengthening Medications with Postoperative Outcomes Following Transforaminal Lumbar Interbody Fusion.

Association of Osteoporosis and Bone-Strengthening Medications with Postoperative Outcomes Following Transforaminal Lumbar Interbody Fusion.

Prescription Trends by Orthopedic Surgery Provider: Review of the Medicare Part D Prescribers - by Provider and Drug, 2013-2021.

Prescription Trends by Orthopedic Surgery Provider: Review of the Medicare Part D Prescribers - by Provider and Drug, 2013-2021.

Drug repurposing for osteoarthritis disease modification in the early 21st century.

Drug repurposing for osteoarthritis disease modification in the early 21st century.

Bisphosphonate-related ocular adverse events: a pharmacovigilance study based on the FAERS database.

Bisphosphonate-related ocular adverse events: a pharmacovigilance study based on the FAERS database.

γ9δ2 T cells detect mevalonate diphosphate via BTN3A3.

γ9δ2 T cells detect mevalonate diphosphate via BTN3A3.

Transdermal delivery of risedronate via spanlastics for osteoporosis: formulation optimization, skin deposition, and pharmacokinetic assessment.

Transdermal delivery of risedronate via spanlastics for osteoporosis: formulation optimization, skin deposition, and pharmacokinetic assessment.

Pharmacovigilance-Based Identification and Mechanistic Exploration of Periodontitis-Related Drugs.

Pharmacovigilance-Based Identification and Mechanistic Exploration of Periodontitis-Related Drugs.

A Systematic Review on the Efficacy of Bisphosphonates on Osteogenesis Imperfecta.

A Systematic Review on the Efficacy of Bisphosphonates on Osteogenesis Imperfecta.

Encapsulating Pt NCs with an AIE effect into a metal-organic framework as a novel fluorescence nanoprobe for discriminatively detecting bisphosphonate drugs.

Encapsulating Pt NCs with an AIE effect into a metal-organic framework as a novel fluorescence nanoprobe for discriminatively detecting bisphosphonate drugs.

Preclinical Study of Pain Neuropeptide Expression in Murine Sensory Neurons Induced by Irradiated Osteoclasts in the Context of Stereotactic Body Radiation Therapy.

Preclinical Study of Pain Neuropeptide Expression in Murine Sensory Neurons Induced by Irradiated Osteoclasts in the Context of Stereotactic Body Radiation Therapy.